Research Article
Potential Role of HMGCS2 in Tumor Angiogenesis in Colorectal Cancer and Its Potential Use as a Diagnostic Marker
Table 1
The characteristic of patients with colorectal cancer.
| Variables | Number of patients (%) | β-hydroxybutyrate (mean ± SEM)∗ |
| Total | 80 | | Age | | | <=50 years | 19 (46.25%) | 0.2458 ± 0.0612 | >50 years | 61 (53.75%) | 0.3475 ± 0.0615 | Gender | | | Male | 45 (56.25%) | 0.2929 ± 0.0477 | Female | 35 (43.75%) | 0.3471 ± 0.0794 | Stage | | | I | 12 (15%) | 0.0900±0.0427 | II | 39 (48.75%) | 0.1700±0.0802 | III | 24 (30%) | 0.1900±0.0726 | IV | 5 (6.25%) | 0.330±0.2874 |
|
|
∗Normal level is 0.03-0.3.
|